CN Patent

CN103923084B — 几种晶型及其制备方法

Assigned to Beijing Crystal Biological Medicine Technology Co Ltd · Expires 2016-08-17 · 10y expired

What this patent protects

本发明提供1‑[(3R)‑3‑[4‑氨基‑3‑(4‑苯氧基苯基)‑1H‑吡唑并[3,4‑D]嘧啶‑1‑基]‑1‑哌啶基]‑2‑丙烯‑1‑酮的无水合物、水合物以及溶剂合物新晶型及其制备方法。本发明提供的几种新晶型，可用于治疗多种病症，特别是可以用于治疗套细胞淋巴癌的病症。

USPTO Abstract

本发明提供1‑[(3R)‑3‑[4‑氨基‑3‑(4‑苯氧基苯基)‑1H‑吡唑并[3,4‑D]嘧啶‑1‑基]‑1‑哌啶基]‑2‑丙烯‑1‑酮的无水合物、水合物以及溶剂合物新晶型及其制备方法。本发明提供的几种新晶型，可用于治疗多种病症，特别是可以用于治疗套细胞淋巴癌的病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN103923084B
Jurisdiction
CN
Classification
—
Expires
2016-08-17
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Crystal Biological Medicine Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.